Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

Condition:   Niemann-Pick Disease, Type C1 Intervention:   Drug: Hydroxypropyl-beta-cyclodextrin Sponsor:   CTD Holdings, Inc. Not yet recruiting - verified October 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials